Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 11764
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 2014  |  Volume : 62  |  Issue : 12  |  Page : 1176

Safe endoresection

1 Duke Eye Center, Duke University, Durham, North Carolina, USA
2 Department of Ophthalmology, University of California - San Francisco, San Francisco, California, USA

Date of Web Publication12-Jan-2015

Correspondence Address:
Dr. Michael I Seider
Duke Eye Center, DUMC 3802, 2351 Erwin Road, Durham, NC 27710
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0301-4738.149157

Rights and Permissions

How to cite this article:
Seider MI, Damato BE. Safe endoresection. Indian J Ophthalmol 2014;62:1176

How to cite this URL:
Seider MI, Damato BE. Safe endoresection. Indian J Ophthalmol [serial online] 2014 [cited 2020 Aug 14];62:1176. Available from: http://www.ijo.in/text.asp?2014/62/12/1176/149157

Dear Editor,

We read with interest the report by Modarres et al. regarding the massive recurrence of choroidal melanoma following endoresection. [1] Readers of the aforementioned article might come to the conclusion that the case presented provides evidence that endoresection performed properly is particularly dangerous. However, the results of this case should not be used to evaluate the safety or efficacy of endoresection because parameters for appropriate patient selection, technique and post-operative surveillance (as described in the literature) were likely not adhered to.

In their article, the authors do not describe the tumor preoperatively in terms of its ultrasonographic measurements, location or extent and leave out other important clinical details such as presence of retinal detachment, tumor involvement of retina or vitreous or extraocular extension. The authors do describe a tumor width of "15 disk diameters," which implies a dimension >20 mm. The authors do cite some of the pioneering work regarding endoresection, [2] but they do not mention that only patients with tumors measuring 8.2 mm in width or less were included in that cohort. A more recent series on endoresection included only patients with tumors measuring 11.1 mm in width or less. [3] Furthermore, the authors describe the tumor in their patient as presenting on "the nasal side of the fundus" - if the tumor was truly >20 mm in diameter and located nasal to the optic nerve, it should have involved the ciliary body, which is not amenable to endoresection. In summary, a choroidal melanoma such as the one described in the present article is much too large and most likely in the wrong anatomical area to be treatable successfully with endoresection.

Furthermore, the authors do not describe their procedure in sufficient detail. Most importantly there is no mention of cryotherapy of the sclerotomy ports, which is an essential part of the procedure to improve safety.

It is also noteworthy that the authors did not identify tumor recurrence in their patient until 5 years had elapsed post-operatively. This suggests a delay in the detection of the tumor recurrence, because reported recurrences of much smaller tumors treated with endoresection have been detected within the first 3 postoperative years. [3],[4] The great extent of the recurrence in this case provides additional evidence that the postoperative surveillance of the patient may have been inadequate. More information on the frequency and method of postoperative examinations would be useful. The authors also do not mention the more recently published favorable long-term results of properly performed endoresection for smaller melanomas. [3]

No surgical procedure is safe unless performed properly. The case presented by Modarres et al. is an important reminder that endoresection for choroidal melanoma should not be performed when enucleation is indicated because of excessively large tumor size. In addition, endoresection is likely best performed by suitably-trained, experienced ocular oncologists who rigorously adhere to accepted selection criteria and who meticulously and skillfully provide adequate postoperative monitoring, which must be life-long.

  References Top

Modarres M, Rezanejad A, Falavarjani KG. Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection. Indian J Ophthalmol 2014;62:731-3.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
Damato B, Groenewald C, McGalliard J, Wong D. Endoresection of choroidal melanoma. Br J Ophthalmol 1998;82:213-8.  Back to cited text no. 2
Konstantinidis L, Groenewald C, Coupland SE, Damato B. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol 2014;98:82-5.  Back to cited text no. 3
García-Arumí J, Zapata MA, Balaguer O, Fonollosa A, Boixadera A, Martinez-Castillo V. Endoresection in high posterior choroidal melanomas: Long-term outcome. Br J Ophthalmol 2008;92:1040-5.  Back to cited text no. 4


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded93    
    Comments [Add]    

Recommend this journal